| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.3B | — | $1.4B | — | -3.2% |
| Op. Income | $125M | — | $155M | — | -19.0% |
| Gross Margin | 15.5% | — | 83.7% | — | -68.2pp |
| Net Margin | 0.1% | — | 5.8% | — | -5.7pp |
| EPS (Diluted) | $0.10 | — | $5.71 | — | -98.2% |
| Free Cash Flow | $109M | — | $194M | — | -44.0% |
| Item | Amount |
|---|---|
| REVENUE | $1.3B |
| Cost of Revenue | $1.1B |
| GROSS PROFIT | $209M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $84M |
| Other Expenses | $0 |
| Operating Expenses | $84M |
| Cost & Expenses | $1.2B |
| OPERATING INCOME | $125M |
| Interest Income | $0 |
| Interest Expense | $42M |
| Other Income/Expenses | -$85M |
| INCOME BEFORE TAX | $41M |
| Income Tax Expense | $39M |
| Net Income from Continuing Ops | $2M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $1M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $1M |
| D&A | $232M |
| EBIT | $125M |
| EBITDA | $358M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $1.3B |
| Cost of Revenue | $1.1B |
| GROSS PROFIT | $209M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $84M |
| Other Expenses | $0 |
| Operating Expenses | $84M |
| Cost & Expenses | $1.2B |
| OPERATING INCOME | $125M |
| Interest Income | $0 |
| Interest Expense | $42M |
| Other Income/Expenses | -$85M |
| INCOME BEFORE TAX | $41M |
| Income Tax Expense | $39M |
| Net Income from Continuing Ops | $2M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $1M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $1M |
| D&A | $232M |
| EBIT | $125M |
| EBITDA | $358M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $1M |
| Depreciation & Amortization | $232M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $36M |
| Other Non-Cash Items | $48M |
| Change in Working Capital | -$16M |
| OPERATING CASH FLOW | $301M |
| Capital Expenditure | -$192M |
| Acquisitions (Net) | $29M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $12M |
| NET CASH FROM INVESTING | -$152M |
| Net Debt Issuance | -$73M |
| Common Stock Repurchased | -$55M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$11M |
| NET CASH FROM FINANCING | -$140M |
| FREE CASH FLOW | $109M |
| Net Change in Cash | $11M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $63M |
| Short-Term Investments | $0 |
| Net Receivables | $257M |
| Inventory | $36M |
| Other Current Assets | $2 |
| TOTAL CURRENT ASSETS | $356M |
| PP&E (Net) | $1.6B |
| Goodwill | $7M |
| Intangible Assets | $0 |
| Long-Term Investments | $3M |
| Tax Assets | $2M |
| Other Non-Current Assets | $6M |
| TOTAL NON-CURRENT ASSETS | $1.6B |
| TOTAL ASSETS | $2.0B |
| Account Payables | $205M |
| Short-Term Debt | $13M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $219M |
| Long-Term Debt | $530M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $66M |
| Other Non-Current Liabilities | -$19M |
| TOTAL NON-CURRENT LIABILITIES | $612M |
| TOTAL LIABILITIES | $831M |
| Common Stock | $1.6B |
| Additional Paid-In Capital | $58M |
| Retained Earnings | -$656M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $120M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.2B |
| Minority Interest | $4M |
| TOTAL EQUITY | $1.2B |
| TOTAL LIABILITIES & EQUITY | $2.0B |
| Total Debt | $578M |
| Net Debt | $515M |
